The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype
Open accessAbstract
Dyslipidemia is associated with a prothrombotic phenotype; however, the mechanisms responsible for enhanced platelet reactivity remain unclear. Proatherosclerotic lipid abnormalities are associated with both enhanced oxidant stress and the generation of biologically active oxidized lipids, including potential ligands for the scavenger receptor CD36, a major platelet glycoprotein. Using multiple mouse in vivo thrombosis models, we now demonstrate that genetic deletion of Cd36 protects mice from hyperlipidemia-associated enhanced platelet reactivity and the accompanying prothrombotic phenotype. Structurally defined oxidized choline glycerophospholipids that serve as high-affinity ligands for CD36 were at markedly increased levels in the plasma of hyperlipidemic mice and in the plasma of humans with low HDL levels, were able to bind platelets via CD36 and, at pathophysiological levels, promoted platelet activation via CD36. Thus, interactions of platelet CD36 with specific endogenous oxidized lipids play a crucial role in the well-known clinical associations between dyslipidemia, oxidant stress and a prothrombotic phenotype.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Platelet hyperreactivity and thrombosis risk are enhanced in the setting of numerous conditions associated with atherosclerotic heart disease, such as hyperlipidemia, oxidant stress, and hyperglycemia (Podrez et al., 2007; Chen et al., 2008; Zhu et al., 2012a).”
From Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk (2016) · cites this paper as Podrez et al., 2007
Citations
Cites
Antiinflammatory Properties of HDL
Barter, P. J., Nicholls, S., Rye, K.-A., Anantharamaiah, G. M., Navab, M., & Fogelman, A. M. (2004) · Circulation Research · doi:10.1161/01.res.0000146094.59640.13 · Cited by 1,394 · cited 1×
“Because anti-inflammatory and antioxidant effects of HDL are well documente”
BackgroundFebbraio, M., Hajjar, D. P., & Silverstein, R. L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14006 · Cited by 1,193 · cited 1×
“CD36 is implicated in a variety of pathological conditions, including atherosclerosis, diabetes and innate immunit”
BackgroundSelf-citationFebbraio, M., Podrez, E. A., Smith, J. D., Hajjar, D. P., Hazen, S. L., Hoff, H. F., Sharma, K., & Silverstein, R. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9259 · Cited by 1,044 · cited 1×
“Absence of CD36 in a mouse model of atherogenesis results in significant inhibition of atherosclerosi”
BackgroundSelf-citationCirculating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E
Huo, Y., Schober, A., Forlow, S. B., Smith, D. F., Hyman, M. C., Jung, S., Littman, D. R., Weber, C., & Ley, K. (2003) · Nature Medicine · doi:10.1038/nm810 · Cited by 1,005 · cited 1×
“Platelet P-selectin mediates the formation of platelet-monocyte aggregates, which have been implicated in several vascular disease processe”
BackgroundCD36 is a sensor of diacylglycerides
Hoebe, K., Georgel, P., Rutschmann, S., Du, X., Mudd, S., Crozat, K., Sovath, S., Shamel, L., Hartung, T., Zähringer, U., et al. (2005) · Nature · doi:10.1038/nature03253 · Cited by 873 · cited 1×
“To address any potential issues related to the mixed genetic background of the Cd36 −/− and Apoe −/− Cd36 −/− mice, we used independently generated, CD36-deficient 'oblivious' mic”
MethodWatson, A. D., Leitinger, N., Navab, M., Faull, K. F., Hörkkö, S., Witztum, J. L., Palinski, W., Schwenke, D., Salomon, R. G., Sha, W., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.21.13597 · Cited by 753
Self-citationCD40L stabilizes arterial thrombi by a β3 integrin–dependent mechanism
André, P., Prasad, K. S. S., Denis, C. V., He, M., Papalia, J. M., Hynes, R. O., Phillips, D. R., & Wagner, D. D. (2002) · Nature Medicine · doi:10.1038/nm0302-247 · Cited by 726
Platelet Function in Hyperlipoproteinemia
Carvalho, A. C. A., Colman, R. W., & Lees, R. S. (1974) · New England Journal of Medicine · doi:10.1056/nejm197402212900805 · Cited by 679
Platelet Hyperreactivity and Prognosis in Survivors of Myocardial Infarction
Trip, M. D., Cats, V. M., van Capelle, F. J. L., & Vreeken, J. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222201 · Cited by 617
Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro
Podrez, E. A., Schmitt, D., Hoff, H. F., & Hazen, S. L. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5549 · Cited by 492
Self-citation
Cited by
Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
Zhu, W., Gregory, J. C., Org, E., Buffa, J. A., Gupta, N., Wang, Z., Li, L., Fu, X., Wu, Y., Mehrabian, M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.011 · Cited by 1,968
“Platelet hyperreactivity and thrombosis risk are enhanced in the setting of numerous conditions associated with atherosclerotic heart disease, such as hyperlipidemia, oxidant stress, and hyperglycemia (Podrez et al., 2007; Chen et al., 2008; Zhu et al., 2012).”
Self-citationFree Radical Lipid Peroxidation: Mechanisms and Analysis
Yin, H., Xu, L., & Porter, N. A. (2011) · Chemical Reviews · doi:10.1021/cr200084z · Cited by 1,937
Mechanisms of Thrombus Formation
Furie, B., & Furie, B. C. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0801082 · Cited by 1,926
CD36, a Scavenger Receptor Involved in Immunity, Metabolism, Angiogenesis, and Behavior
Silverstein, R. L., & Febbraio, M. (2009) · Science Signaling · doi:10.1126/scisignal.272re3 · Cited by 1,141
Self-citationTriggers, targets and treatments for thrombosis
Mackman, N. (2008) · Nature · doi:10.1038/nature06797 · Cited by 1,188
“A recent study showed that oxidized low-density lipoproteins activate platelets by binding to CD36 and that the prothrombotic phenotype of mice deficient in apolipoprotein E, which have high concentrations of low-density lipoprotein in the circulation, is reduced by deletion of Cd36 (ref”
BackgroundNew Fundamentals in Hemostasis
Versteeg, H. H., Heemskerk, J. W. M., Levi, M., & Reitsma, P. H. (2013) · Physiological Reviews · doi:10.1152/physrev.00016.2011 · Cited by 1,126
“Its role in the thrombus may be confined to conditions of dyslipidemia and oxidant stress (232).”
BackgroundScavenger receptors in homeostasis and immunity
Canton, J., Neculai, D., & Grinstein, S. (2013) · Nature Reviews Immunology · doi:10.1038/nri3515 · Cited by 838
Platelets, inflammation and tissue regeneration
Nurden, A. (2011) · Thrombosis and Haemostasis · doi:10.1160/ths10-11-0720 · Cited by 791
Arterial thrombosis—insidious, unpredictable and deadly
Jackson, S. P. (2011) · Nature Medicine · doi:10.1038/nm.2515 · Cited by 685
Generation and Biological Activities of Oxidized Phospholipids
Bochkov, V. N., Oskolkova, O. V., Birukov, K. G., Levonen, A.-L., Binder, C. J., & Stöckl, J. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2597 · Cited by 610
CD36, a scavenger receptor implicated in atherosclerosis
Park, Y. M. (2014) · Experimental & Molecular Medicine · doi:10.1038/emm.2014.38 · Cited by 517
A Brief Review of Cardiovascular Diseases, Associated Risk Factors and Current Treatment Regimes
Flora, G. D., & Nayak, M. K. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190925163827 · Cited by 476
Molecular Biology of Atherosclerosis
Hopkins, P. N. (2013) · Physiological Reviews · doi:10.1152/physrev.00004.2012 · Cited by 459
CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate
Chen, Y., Zhang, J., Cui, W., & Silverstein, R. L. (2022) · Journal of Experimental Medicine · doi:10.1084/jem.20211314 · Cited by 454
Self-citationPathological aspects of lipid peroxidation
Negre-Salvayre, A., Auge, N., Ayala, V., Basaga, H., Boada, J., Brenke, R., Chapple, S., Cohen, G., Feher, J., Grune, T., et al. (2010) · Free Radical Research · doi:10.3109/10715762.2010.498478 · Cited by 449
“Interestingly, plasma circulating oxPLs could bind and activate platelets via CD36, thereby linking hyperlipidemia, oxidative stress and prothrombotic events [131].”
BackgroundOxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands
West, X. Z., Malinin, N. L., Merkulova, A. A., Tischenko, M., Kerr, B. A., Borden, E. C., Podrez, E. A., Salomon, R. G., & Byzova, T. V. (2010) · Nature · doi:10.1038/nature09421 · Cited by 431
Self-citationPark, Y. M., Febbraio, M., & Silverstein, R. L. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35535 · Cited by 406
Self-citationThe role of oxidized phospholipids in atherosclerosis
Berliner, J. A., Leitinger, N., & Tsimikas, S. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800074-jlr200 · Cited by 403
New Insights into the Role of Inflammation in the Pathogenesis of Atherosclerosis
Wu, M.-Y., Li, C.-J., Hou, M.-F., & Chu, P.-Y. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102034 · Cited by 392
“activation via Src kinases and Rho kinase signaling pathways [30,34,35].”
BackgroundChemistry of phospholipid oxidation
Reis, A., & Spickett, C. M. (2012) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2012.02.002 · Cited by 368
Yang, S., Li, X., Yang, F., Zhao, R., Pan, X., Liang, J., Tian, L., Li, X., Liu, L., Xing, Y., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01360 · Cited by 345
“The risk of platelet hyperreactivity and thrombosis is increased in many conditions associated with atherosclerotic CVD, such as oxidative stress and hyperlipidemia (Podrez et al., 2007; Chen et al., 2008).”
BackgroundThe biology behind the atherothrombotic effects of cigarette smoke
Csordas, A., & Bernhard, D. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.8 · Cited by 343
Xu, X. R., Zhang, D., Oswald, B. E., Carrim, N., Wang, X., Hou, Y., Zhang, Q., Lavalle, C., McKeown, T., Marshall, A. H., et al. (2016) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2016.1200008 · Cited by 338
Xu, X. R., Yousef, G. M., & Ni, H. (2018) · Blood · doi:10.1182/blood-2017-05-743187 · Cited by 325
Dyslipidaemia in nephrotic syndrome: mechanisms and treatment
Agrawal, S., Zaritsky, J. J., Fornoni, A., & Smoyer, W. E. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.155 · Cited by 325
The Lipid Whisker Model of the Structure of Oxidized Cell Membranes
Greenberg, M. E., Li, X.-M., Gugiu, B. G., Gu, X., Qin, J., Salomon, R. G., & Hazen, S. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707348200 · Cited by 299
Self-citationThe role of CD36 in cardiovascular disease
Shu, H., Peng, Y., Hang, W., Nie, J., Zhou, N., & Wang, D. W. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvaa319 · Cited by 277
“Animal experiments showed that the deletion of the CD36 gene protects mice from the increased platelet reactivity associated with hyperlipidaemia and the accompanying thrombotic phenotype.(184) OxLDL-mediated CD36 signal transduction can activate platelets in a variety of ways.”
BackgroundQi, Z., Hu, L., Zhang, J., Yang, W., Liu, X., Jia, D., Yao, Z., Chang, L., Pan, G., Zhong, H., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.046290 · Cited by 268
“In this study, we demonstrated that (1) PCSK9 in plasma directly enhances platelet activation and in vivo thrombosis; (2) PCSK9 binds to platelet CD36 receptor and thus activates Src, ERK5, and JNK, increases the generation of ROS, and activates p38/cPLA2/COX-1/TXA2 signaling pathways downstream of CD36, as well, to e…”
BackgroundROS in Platelet Biology: Functional Aspects and Methodological Insights
Masselli, E., Pozzi, G., Vaccarezza, M., Mirandola, P., Galli, D., Vitale, M., Carubbi, C., & Gobbi, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144866 · Cited by 229
“The deletion of these receptors in animal models of artery thrombosis has been associated to a marked reduction in thrombus formation [76,77].”
BackgroundLipoprotein receptor signalling in atherosclerosis
Mineo, C. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvz338 · Cited by 219
“The work by Acton et al. identified SR-BI as the high-affinity HDL receptor, which mediates the selective uptake of HDLassociated cholesterol ester (CE) into the liver.239 SR-BI also facilitates the bidirectional flux of free cholesterol (FC) between cells and HDL.241,242 A major role of SR-BI in lipoprotein metabolis…”
BackgroundInfluentialOxidative risk for atherothrombotic cardiovascular disease
Leopold, J. A., & Loscalzo, J. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.09.009 · Cited by 215
Role of Phospholipid Oxidation Products in Atherosclerosis
Lee, S., Birukov, K. G., Romanoski, C. E., Springstead, J. R., Lusis, A. J., & Berliner, J. A. (2012) · Circulation Research · doi:10.1161/circresaha.111.256859 · Cited by 204
“(8) Oxidized phosphatidylcholine-containing phospholipids (Ox-PL) acting on Toll-like receptor (TLR)2, TLR4/6/cluster determinant 36 (CD36), and platelet activating factor (PAF) receptor cause some monocytes to differentiate into M1 macrophages producing chemokines.”
BackgroundChen, K., Febbraio, M., Li, W., & Silverstein, R. L. (2008) · Circulation Research · doi:10.1161/circresaha.108.172064 · Cited by 202
Self-citationKennedy, D. J., Kuchibhotla, S., Westfall, K. M., Silverstein, R. L., Morton, R. E., & Febbraio, M. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvq360 · Cited by 197
Self-citationArias, N., Arboleya, S., Allison, J., Kaliszewska, A., Higarza, S. G., Gueimonde, M., & Arias, J. L. (2020) · Nutrients · doi:10.3390/nu12082340 · Cited by 196
Chu, L. H., Indramohan, M., Ratsimandresy, R. A., Gangopadhyay, A., Morris, E. P., Monack, D. M., Dorfleutner, A., & Stehlik, C. (2018) · Nature Communications · doi:10.1038/s41467-018-03409-3 · Cited by 193
A 2-Step Mechanism of Arterial Thrombus Formation Induced by Human Atherosclerotic Plaques
Reininger, A. J., Bernlochner, I., Penz, S. M., Ravanat, C., Smethurst, P., Farndale, R. W., Gachet, C., Brandl, R., & Siess, W. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.11.051 · Cited by 186
Meikle, P. J., Wong, G., Barlow, C. K., & Kingwell, B. A. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.001 · Cited by 184
Yan, H., Naadiya, C., Yiming, W., Reid, C., Alexandra, M., & Heyu, N. (2015) · The Journal of Biomedical Research · doi:10.7555/jbr.29.20150121 · Cited by 178
Oxidized Phospholipids as Endogenous Pattern Recognition Ligands in Innate Immunity
Hazen, S. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r700054200 · Cited by 176
Self-citationMagwenzi, S., Woodward, C., Wraith, K. S., Aburima, A., Raslan, Z., Jones, H., McNeil, C., Wheatcroft, S., Yuldasheva, N., Febbriao, M., et al. (2015) · Blood · doi:10.1182/blood-2014-05-574491 · Cited by 174
“In mice, dyslipidemia enhances thrombosis in vivo, with the pathological phenotype corrected by deletion of CD36.”
BackgroundInfluentialPanigrahi, S., Ma, Y., Hong, L., Gao, D., West, X. Z., Salomon, R. G., Byzova, T. V., & Podrez, E. A. (2013) · Circulation Research · doi:10.1161/circresaha.112.274241 · Cited by 172
“We have previously shown that factors such as specific oxidized phospholipids that are present in circulation in hyperlipidemic ApoE mice can directly activate platelets via receptors expressed on the surface of resting platelets.(5) Although we did not show in this study that endogenously produced CAPs contribute to…”
BackgroundMethodSelf-citationOwens, A. P., Passam, F. H., Antoniak, S., Marshall, S. M., McDaniel, A. L., Rudel, L., Williams, J. C., Hubbard, B. K., Dutton, J.-A., Wang, J., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58969 · Cited by 171
The innate immune response to products of phospholipid peroxidation
Weismann, D., & Binder, C. J. (2012) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2012.01.018 · Cited by 170
PCSK9 Biology and Its Role in Atherothrombosis
Barale, C., Melchionda, E., Morotti, A., & Russo, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115880 · Cited by 171
“Activated platelets interact with endothelial cells of inflamed or atherosclerotic arteries and release platelet factors that trigger an inflammatory reaction of endothelial cells and/or facilitate leukocyte—endothelial interactions [109,110].”
BackgroundGhosh, A., Li, W., Febbraio, M., Espinola, R. G., McCrae, K. R., Cockrell, E., & Silverstein, R. L. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34904 · Cited by 169
“We previously reported, using a carotid artery FeCl3 injury model, that thrombosis times in CD36– mice were not significantly different from those in WT animals (28).”
MethodResultInfluentialSelf-citationPlatelet Factor 4 Mediates Inflammation in Experimental Cerebral Malaria
Srivastava, K., Cockburn, I. A., Swaim, A., Thompson, L. E., Tripathi, A., Fletcher, C. A., Shirk, E. M., Sun, H., Kowalska, M. A., Fox-Talbot, K., et al. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.07.003 · Cited by 168
“Recently, ligand binding of platelet CD36 has been shown to stimulate platelet activation (Podrez et al., 2007).”
BackgroundZhu, W., Buffa, J. A., Wang, Z., Warrier, M., Schugar, R., Shih, D. M., Gupta, N., Gregory, J. C., Org, E., Fu, X., et al. (2018) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14234 · Cited by 161
“Platelet hyperresponsiveness and thrombosis risk are associated with numerous conditions that predispose to CVD such as hyperlipidemia[3], oxidative stress[4] and hyperglycemia[5].”
Self-citationAspirin for Primary Prevention of Cardiovascular Events in Relation to Lipoprotein(a) Genotypes
Lacaze, P. A., Bakshi, A., Riaz, M., Polekhina, G., Owen, A. J., Bhatia, H. S., Natarajan, P., Wolfe, R. S., Beilin, L. J., Nicholls, S. J., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.07.027 · Cited by 169
Platelet Function in Cardiovascular Disease: Activation of Molecules and Activation by Molecules
Khodadi, E. (2019) · Cardiovascular Toxicology · doi:10.1007/s12012-019-09555-4 · Cited by 154
Miller, Y. I., Choi, S.-H., Fang, L., & Tsimikas, S. (2010) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-90-481-8622-8_8 · Cited by 161
“It has been reported that CD36 is involved in oxidized lipid-induced platelet activation and that it mediates a pro-thrombotic phenotype under dislipidemic conditions (Podrez et al., 2007).”
BackgroundFuture innovations in anti‐platelet therapies
Barrett, N. E., Holbrook, L., Jones, S., Kaiser, W. J., Moraes, L. A., Rana, R., Sage, T., STANLEY, R. G., Tucker, K. L., Wright, B., et al. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.151 · Cited by 162
“Platelet CD36 has been recently identified as a missing link in the association between dyslipidaemia and a prothrombotic phenotype (Podrez et al., 2007).”
BackgroundInfluentialPlatelet-derived S100 family member myeloid-related protein-14 regulates thrombosis
Wang, Y., Fang, C., Gao, H., Bilodeau, M. L., Zhang, Z., Croce, K., Liu, S., Morooka, T., Sakuma, M., Nakajima, K., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci70966 · Cited by 146
“5% FeCl3 (25), we did not observe a thrombosis defect in Cd36–/– mice using the photochemical injury model.”
Self-citationSerbulea, V., Upchurch, C. M., Schappe, M. S., Voigt, P. E., DeWeese, D. E., Desai, B. N., Meher, A. K., & Leitinger, N. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1800544115 · Cited by 161
“(70), we found micromolar levels of OxPL species in murine whole blood, and a significant increase in response to Fig.”
BackgroundMethodCD36 participates in a signaling pathway that regulates ROS formation in murine VSMCs
Li, W., Febbraio, M., Reddy, S. P., Yu, D. Y., Yamamoto, M. P., & Silverstein, R. L. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42823 · Cited by 144
“To this point, evidence linking CD36 to human atherothrombotic disease includes reports that CD36 genetic polymorphisms are associated with myocardial infarction (36, 37) and that hyperlipidemia is associated with CD36-dependent platelet hyperreactivity (2).”
BackgroundSelf-citationAfonyushkin, T., Oskolkova, O., Philippova, M., Resink, T. J., Erné, P., Binder, B. R., & Bochkov, V. N. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.204354 · Cited by 149
Washington, A. V., Gibot, S., Acevedo, I., Gattis, J., Quigley, L., Feltz, R., Mota, A. D. L., Schubert, R. L., Gómez‐Rodríguez, J., Cheng, J., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36175 · Cited by 150
Thomas, C. P., Morgan, L. T., Maskrey, B. H., Murphy, R. C., Kühn, H., Hazen, S. L., Goodall, A. H., Hamali, H. A., Collins, P. W., & O’Donnell, V. B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.078428 · Cited by 142
Self-citationCD36 and lipid metabolism in the evolution of atherosclerosis
Zhao, L., Varghese, Z., Moorhead, J. F., Chen, Y., & Ruan, X. Z. (2018) · British Medical Bulletin · doi:10.1093/bmb/ldy006 · Cited by 140
High‐density lipoprotein: A potent inhibitor of inflammation
Murphy, A. J., & Woollard, K. J. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2009.05338.x · Cited by 148
“A potential mechanism for pro-atherogenic intraplaque haemorrhaging by ox-HDL is an increased clotting time, thereby promoting neutrophil infiltration and release of proteases, such as matrix metalloproteinases, which may ultimately result in plaque rupture.61,62 Although SR-BI is indeed a receptor for other lipoprote…”
BackgroundOxidized low‐density lipoprotein in inflammation‐driven thrombosis
Obermayer, G., Afonyushkin, T., & Binder, C. J. (2018) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13925 · Cited by 141
Srikanthan, S., Li, W., Silverstein, R. L., & McIntyre, T. M. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12712 · Cited by 134
Self-citationNavarese, E. P., Kołodziejczak, M. M., Winter, M., Alimohammadi, A., Lang, I. M., Buffon, A., Lip, G. Y. H., & Siller-Matula, J. M. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.10.084 · Cited by 140
Ghosh, A., Murugesan, G., Chen, K., Zhang, L., Wang, Q. K., Febbraio, M., Anselmo, R. M., Marchant, K., Barnard, J., & Silverstein, R. L. (2011) · Blood · doi:10.1182/blood-2011-02-338582 · Cited by 137
Self-citationPlatelet biology and function: plaque erosion vs. rupture
Baaten, C. C. F. M. J., Nagy, M., Bergmeier, W., Spronk, H. M. H., & van der Meijden, P. E. J. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad720 · Cited by 155
“112,113 Furthermore, genetic knockout of CD36 corrected the prothrombotic phenotype of hyperlipidaemic ApoE − / − mice as time to vessel occlusion and tail bleeding times were comparable with those of wild-type mice.”
BackgroundResultGebremeskel, S., LeVatte, T. L., Liwski, R., Johnston, B., & Bezuhly, M. (2014) · International Journal of Cancer · doi:10.1002/ijc.28947 · Cited by 138
“Finally, the doses of ticagrelor and clopidogrel used in our study were based on antiplatelet activity established in the cardiovascular literature as well as our own preliminary dose-response experiments, and did not take into account the potential disruption of ADP-mediated regulatory signaling between platelets and…”
MethodPlatelet lipoprotein interplay: trigger of foam cell formation and driver of atherosclerosis
Siegel-Axel, D. I., Daub, K., Seizer, P., Lindemann, S., & Gawaz, M. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn015 · Cited by 129
Inflammation, atherosclerosis, and arterial thrombosis: Role of the scavenger receptor CD36
Silverstein, R. L. (2009) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.76.s2.06 · Cited by 125
Self-citationPleiotropic effects of oxidized phospholipids
Bochkov, V. N., Gesslbauer, B., Mauerhofer, C., Philippova, M., Erné, P., & Oskolkova, O. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.12.034 · Cited by 141
High‐density lipoproteins, platelets and the pathogenesis of atherosclerosis
Nofer, J., Brodde, M. F., & Kehrel, B. E. (2010) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2010.05377.x · Cited by 125
Zhu, W., Li, W., & Silverstein, R. L. (2012) · Blood · doi:10.1182/blood-2011-10-387506 · Cited by 135
“a pro-thrombotic state associated with generation of oxLDL and CD36-mediated platelet hyper-reactivity.(8,9,10) To separate the potential confounding effect of hyperlipidemia in the current studies we used western diet fed C57Bl/6 mice as an additional control.”
MethodSelf-citationGreig, F. H., Kennedy, S., & Spickett, C. M. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.481 · Cited by 135
“have been reported in plasma samples from LDL receptor knockout (Ldlr−/−) mice on a Western diet and normotriglyceridemic human volunteers [46].”
BackgroundKar, N. S., Ashraf, M. Z., Valiyaveettil, M., & Podrez, E. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709195200 · Cited by 122
Self-citationOskolkova, O., Afonyushkin, T., Preinerstorfer, B., Bicker, W., von Schlieffen, E., Hainzl, E., Demyanets, S., Schabbauer, G., Lindner, W. F., Tselepis, A. D., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903594 · Cited by 119
“These data are in good agreement with previous estimates of OxPC levels in human and mouse plasma (32, 33).”
ResultZhao, Y., Miao, H., Cheng, X., & Wei, F. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.09.005 · Cited by 126
Regulation of oxidized platelet lipidome: implications for coronary artery disease
Chatterjee, M., Rath, D., Schlotterbeck, J., Rheinlaender, J., Walker-Allgaier, B., Alnaggar, N., Zdanytė, M., Müller, I. I., Borst, O., Geisler, T., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx146 · Cited by 117
LDL oxidation by platelets propagates platelet activation via an oxidative stress-mediated mechanism
Carnevale, R., Bartimoccia, S., Nocella, C., Santo, S. D., Loffredo, L., Illuminati, G., Lombardi, E., Boz, V., Ben, M. D., Marco, L. D., et al. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.08.041 · Cited by 116
“Experimental studies highlighted the pathophysiologic relevance of these findings as in hyperlipidemic animals and humans ox-LDL circulate in human blood at concentration that may favor platelet activation and thrombus growth [5].”
Cholesterol in platelet biogenesis and activation
Wang, N., & Tall, A. R. (2016) · Blood · doi:10.1182/blood-2016-01-631259 · Cited by 115
“Hyperlipidemia increases platelet activation likely via multiple mechanisms.(28,29) Oxidized lowdensity lipoprotein or oxidized phospholipids, which are increased in hyperlipidemia,(28,30) serve as ligands of platelet CD36 and activate platelets.”
BackgroundAn Insight into Recent Advances on Platelet Function in Health and Disease
Chaudhary, P. K., Kim, S., & Kim, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116022 · Cited by 144
Leonarduzzi, G., Gamba, P., Gargiulo, S., Biasi, F., & Poli, G. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.09.031 · Cited by 121
“Moreover, it has been suggested that oxPLs could stimulate formation of platelet-monocyte aggregates, an event that may play a role in the pathogenesis of vascular diseases, by enhancing P-selectin expression [178].”
BackgroundValiyaveettil, M., Kar, N. S., Ashraf, M. Z., Byzova, T. V., Febbraio, M., & Podrez, E. A. (2007) · Blood · doi:10.1182/blood-2007-08-107813 · Cited by 108
“Studies using murine CD36–/– or SR-BI–/– platelets demonstrated that the anti-thrombotic activity of OxHDL depends on platelet SR-BI but not CD36.”
BackgroundMethodInfluentialSelf-citationAntiatherogenic Functionality of High Density Lipoprotein: How Much versus How Gooden-subtitle=
Sviridov, D., Mukhamedova, N., Remaley, A. T., Chin-Dusting, J. P. F., & Nestel, P. J. (2008) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.e571 · Cited by 105
Oxidized phosphatidylcholine induces the activation of NLRP3 inflammasome in macrophages
Yeon, S. H., Yang, G., Lee, H., & Lee, J. Y. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3vma1215-579rr · Cited by 110
Ravandi, A., Leibundgut, G., Hung, M., Patel, M. P., Hutchins, P. M., Murphy, R. C., Prasad, A., Mahmud, E., Miller, Y. I., Dennis, E. A., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.01.055 · Cited by 111
“For example, they mediate endothelial/monocyte dysfunction and bioactivity(23,24) and are important ligands for scavenger receptors on macrophages(22,25) and platelets(10), which in turn lead to foam cell formation, release of inflammatory cytokines, and platelet aggregation(5,26,27).”
BackgroundOxidized Phospholipids Promote NETosis and Arterial Thrombosis in LNK(SH2B3) Deficiency
Dou, H., Kotini, A. G., Liu, W., Fidler, T., Endo‐Umeda, K., Sun, X., Olszewska, M., Xiao, T., Abramowicz, S., Yalçınkaya, M., et al. (2021) · Circulation · doi:10.1161/circulationaha.121.056414 · Cited by 103
HUANG, Z. S., Zeng, C., Zhu, L., Jiang, L., Li, N., & Hu, H. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03859.x · Cited by 99
Handberg, A., Skjelland, M., Michelsen, A. E., Sagen, E. L., Krohg‐Sørensen, K., Russell, D., Dahl, A., Ueland, T., Øie, E., Aukrust, P., et al. (2008) · Stroke · doi:10.1161/strokeaha.108.517128 · Cited by 99
Tang, W. H. W., Wu, Y., Nicholls, S. J., & Hazen, S. L. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.152827 · Cited by 98
Self-citationHandberg, A., Højlund, K., Gastaldelli, A., Flyvbjerg, A., Dekker, J. M., Petrie, J. R., Piatti, P., Beck‐Nielsen, H., & the RISC Investigators (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02442.x · Cited by 99
Platelet CD36 promotes thrombosis by activating redox sensor ERK5 in hyperlipidemic conditions
Yang, M., Cooley, B. C., Li, W., Chen, Y., Vasquez-Vivar, J. M., Scoggins, N. O., Cameron, S. J., Morrell, C. N., & Silverstein, R. L. (2017) · Blood · doi:10.1182/blood-2016-11-750133 · Cited by 95
Self-citationIkmal, S. I. Q. S., Huri, H. Z., Vethakkan, S. R., & Ahmad, W. A. W. (2013) · International Journal of Endocrinology · doi:10.1155/2013/698567 · Cited by 93
“Furthermore, elevated FFA in monocytes and macrophages also stimulate CD36 expression through PPAR-γdependent mechanism [26, 31, 33].”
BackgroundNADPH oxidase 2 (NOX2): A key target of oxidative stress-mediated platelet activation and thrombosis
Eduardo Fuentes, Q., Gibbins, J. M., Holbrook, L., & Palomo, I. F. (2018) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2018.03.001 · Cited by 93
“The interactions of platelet CD36 with 14 endogenous oxidized lipids play a crucial role in the prothrombotic phenotype (54).”
BackgroundKim, E., Tolhurst, A. T., Qin, L. Y., Chen, X.-Y., Febbraio, M., & Cho, S. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0982-08.2008 · Cited by 81
“Consistent with our result, Podrez et al. (2007) demonstrated recently that a novel family of oxidized choline glycerophospholipids, which exhibit high affinity for CD36, is significantly increased in hyperlipidemic plasma and indicated a prothrombotic role for platelet CD36 in hyperlipidemia.”
ResultSelf-citationvon Schlieffen, E., Oskolkova, O., Schabbauer, G., Грубер, Ф., Blüml, S., Genest, M., Kadl, A., Marsik, C. L., Knapp, S., Chow, J. C., et al. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.173799 · Cited by 94
Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo
Momi, S., Falcinelli, E., Giannini, S., Ruggeri, L., Cecchetti, L., Corazzi, T., Libert, C., & Gresele, P. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20090687 · Cited by 89
“Several molecules that facilitate the activation of platelets by primary stimuli, potentially transforming a normal hemostatic response in the formation of an occlusive thrombus, have been described recently (Podrez et al., 2007; Gresele et al., 2008a).”
BackgroundPlatelets as therapeutic targets to prevent atherosclerosis
Nording, H., Baron, L., & Langer, H. F. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.05.018 · Cited by 91
Oxidized phospholipid modification of lipoprotein(a): Epidemiology, biochemistry and pathophysiology
Koschinsky, M. L., & Boffa, M. B. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.04.001 · Cited by 100
Davies, S. S., & Guo, L. (2014) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2014.03.002 · Cited by 98
Platelets, a Key Cell in Inflammation and Atherosclerosis Progression
Huilcamán, R., Venturini, W., Fuenzalida, L., Cayo, Á., Segovia, R., Valenzuela, C. A., Brown, N. E., & Moore‐Carrasco, R. (2022) · Cells · doi:10.3390/cells11061014 · Cited by 87
Driscoll, W. S., Vaisar, T., Tang, J., Wilson, C. L., & Raines, E. W. (2013) · Circulation Research · doi:10.1161/circresaha.112.300683 · Cited by 89
Metadata
- Authors
- Podrez, E. A., Byzova, T. V., Febbraio, M., Salomon, R. G., Ma, Y., Valiyaveettil, M., Poliakov, E., Sun, M., Finton, P. J., Curtis, B. R., Chen, J., Zhang, R., Silverstein, R. L., & Hazen, S. L.
- Affiliations
- Cleveland Clinic (US)
- Case Western Reserve University (US)
- Versiti Blood Center of Wisconsin (US)
- Corresponding author
- Podrez, Eugene A
- ORCID
- Venue
- Nature Medicine
- Published
- 2007-08-26
- Volume
- 13
- Issue
- 9
- Pages
- 1086-1095
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- PMC
- PMC3042888
- OpenAlex
- W2029684068
- Cited by
- 513
- References
- 47
- Citations by year
- 2026: 25 · 2025: 24 · 2024: 18 · 2023: 29 · 2022: 32 · 2021: 27 · 2020: 27 · 2019: 25 · 2018: 23 · 2017: 24 · 2016: 16 · 2015: 27 · 2014: 26 · 2013: 28 · 2012: 36
- FWCI
- 19.90
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (HL071625., P01HL046403, HL053315, HL 073311, HL076491, HL-072942, R01HL070083, P50 HL-81011, HL077107, HL077213, P01HL072942, P50HL077107, P01HL077107, R01HL077213, P01HL076491, HL 70621, HL70083, R01HL053315, HL-46403, P01HL073311, R01HL070621, P50HL081011, R01HL071625)
- National Center for Research Resources (M01RR018390)
- Topics
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Keywords
- hyperlipidemia, oxidative stress, prothrombotic phenotype, oxidized lipids, platelet activation, scavenger receptors, dyslipidemia, thrombosis, HDL cholesterol
- MeSH terms
- Animals, Blood Platelets, Humans, Hyperlipidemias, Male, Phenotype, Phospholipids, Prothrombin, Thrombosis, Platelet Activation, Antigens, CD, Gene Deletion, Mice, Knockout, Oxidative Stress, CD36 Antigens, Dyslipidemias, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.